Struggling Endo's write-downs pass $5B for 2017 thanks to Opana, mesh, restructuring
admin 8th August 2017 Uncategorised 0Back in February, Endo took a whopping $3.5 billion write-down—but that wouldn’t be it for the year. On Tuesday, the company reported $725 million in impairment charges, thanks largely to the restructuring of its manufacturing network and its pulling of pain med Opana ER from the market.
More: Struggling Endo's write-downs pass B for 2017 thanks to Opana, mesh, restructuring
Source: fierce